Introduction. Adult ADHD in the Real World: From Clinical Trials to Clinical Practice.

Slides:



Advertisements
Similar presentations
A daily dose of 400 mg efavirenz (EFV) is non-inferior to the standard 600 mg dose: week 48 data from the ENCORE1 study, a randomised, double-blind, placebo.
Advertisements

Pharmacy & The IRB Linda Sailor, BS, PharmD Rania Sadaka, BS, PharmD May 2015.
Statin Myopathy (AHA/ACC/NHLBI)
Glaucoma.
RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL
Making Decisions With Your Osteoarthritis Patients
Gout Management.
PCP Perspectives Pathophysiologic Principles in the Management of Hyperkalemia.
Optimizing Therapy for Osteoarthritis
Pseudomonas Lung Infections in Cystic Fibrosis
Access to NOAC Therapy:
Introduction. Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Endocrine System.
MANAGING GLAUCOMA:.
Modern Strategies for Basal Insulin Use in T2D
Pediatric Antiepileptic Treatment Strategies
COPD Management.
Emergency Analgesia in the Trauma Setting in Adults
PCP Perspectives Clinical Considerations in Hyperkalemia
Dual Bronchodilation in COPD: From Clinical Trial Evidence to Clinical Practice.
Optimizing Outcomes in the Management of GIST
Resistant Hypertension
Surveying the Safety of NOACs in the Real World
Optimal Use of New Fentanyl Formulations for BTCP in Asia
Beyond Statin Therapy.
Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.
Chronic Idiopathic Urticaria
When Would You Use Single Inhaler Triple Therapy in COPD?
Program Introduction. Monoclonal Antibodies and Immunogenicity: Relevance to Clinical Practice?
Managing gBRCA-Positive Metastatic Breast Cancer
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.
Is it Time for a Paradigm Change in HIV Management?
Access to NOAC Therapy:
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Evaluating Next-Generation BTK Inhibitors
Hyperhidrosis Is Burdensome!
Atopic Dermatitis. Introduction to a Clinical Course On New Developments In Atopic Dermatitis.
From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP
A Primer on Medication Delivery Systems in COPD Management
Current and Future Perspectives on Migraine Prevention Therapy
Diagnosing Focal Epilepsy: A Clinical Case
New Recommendations on How to Stage Hidradenitis Suppurativa
Introduction. Clinical Scenario: Encouraging Adherence in Patients with Schizophrenia.
Clinicians' Corner in Dyslipidemia
Providing Hope and Opportunity
Maintenance Therapy in Advanced Ovarian Cancer
A Primer on Medication Delivery Systems in COPD Management
Battling the Flu: Latest Advances in the Influenza Treatment Arsenal
Scientific Update.
Application of Biosimilars in RA IN Clinical Practice: Key Issues and Challenges  
Defining Patient-Centered Care: Spotlight on Advanced Non-Small Cell Lung Cancer.
Breaking News in Pemphigus Vulgaris and the Latest Updates for Your Practice.
Optimizing Joint Health in Hemophilia
Critical Decision Points in Insomnia
Patient and Clinician Perspectives on Preventive Therapy for Migraine
The Patient With Early Stage MF-CTCL
Secondary Progressive Multiple Sclerosis: What Do We Know and Where Are We Heading?
Peanut Allergy Immunotherapy
Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition
The Research Question Lateral epicondylosis (tennis elbow) is common, debilitating and often refractory to routine care. Prolotherapy, an injection-based.
PCSK9 Inhibitors and Statin Intolerance
Optimizing Treatment of Refractory Gout
Uptitration of Medications in HF: Start Low but Aim High and Stay High
Patient and Clinician Perspectives on Preventive Therapy for Migraine
Empowering Patients and Prescribers to Improve Treatment Adherence in Schizophrenia.
Balancing the Risks and Benefits of Multidrug Regimens in the Clinical Management of Nontuberculous Mycobacterial Lung Disease.
Widening the Options for Major Depressive Disorder
Expert Perspectives.
What's New in NOACs in AF?.
Taking a Closer Look at Probiotic Efficacy
Presentation transcript:

Adult ADHD in the Real World: From Clinical Trials to Clinical Practice

Introduction

Adult ADHD and Areas of Daily Living

Reasons for Treatment Discontinuation: Systematic Review

Optimizing Approaches to Treatment and Adherence

Adherence to Initial ADHD Medication Among Adults

Traffic Accident Reduction and Medication

ADHD Medications Approved in Sweden

Combining Perspectives From Clinical Research and Real-Life Practice

Clinical Trial in Adult ADHD With a Dose Optimization Phase

Incidence of Adverse Events in the Double-Blind Maintenance of Effect Phase

Different Approaches to Dose Optimization

Clinician Experience With Dose Optimization

Factors to Consider in Dose Optimization

Choosing the Appropriate Medication

Swedish ADHD Treatment Guidelines

Swedish ADHD Treatment Guidelines: Pharmacological Recommendations

Risk of Drug Misuse Decreased on ADHD Medication

Concluding Remarks

Abbreviations